Dongxu Wang
- Molecular Biology top 10%
- Cancer Research top 5%
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Hepatology top 2%
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (19 papers)Cancer Immunotherapy and Biomarkers (17 papers)Liver Disease Diagnosis and Treatment (14 papers)
- Cited by
- Cancer ResearchHepatologyOncology
- Journals
- Nature CommunicationsSHILAP Revista de lepidopterologíaThe Journal of Physical Chemistry B
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Dongxu Wang
94 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 127
- Molecular Biology 746
- Cancer Research 633
- Oncology 563
- Pulmonary and Respiratory Medicine 485
- Hepatology 303
Countries citing papers authored by Dongxu Wang
This map shows the geographic impact of Dongxu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongxu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongxu Wang more than expected).
Fields of papers citing papers by Dongxu Wang
This network shows the impact of papers produced by Dongxu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongxu Wang. The network helps show where Dongxu Wang may publish in the future.
Co-authorship network of co-authors of Dongxu Wang
This figure shows the co-authorship network connecting the top 25 collaborators of Dongxu Wang. A scholar is included among the top collaborators of Dongxu Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongxu Wang. Dongxu Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 5 | |
| 5 | 4 | |
| 6 | 4 | |
| 7 | 5 | |
| 8 | 7 | |
| 9 | 8 | |
| 10 | 9 | |
| 11 | 8 | |
| 12 | 14 | |
| 13 | 22 | |
| 14 | 3 | |
| 15 | 6 | |
| 16 | 23 | |
| 17 | 80 | |
| 18 | 99 | |
| 19 | 1 | |
| 20 | Construction of sense and antisense human heparanase and green fluorescent protein eukaryotic co--expressing vectors and their expression in lung cancer cell lines | 1 |
About Dongxu Wang
Dongxu Wang is a scholar working on Hepatology, Cancer Research and Oncology, having authored 102 papers that have together received 1.9k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (19 papers), Cancer Immunotherapy and Biomarkers (17 papers) and Liver Disease Diagnosis and Treatment (14 papers). The work is most often cited by research in Cancer Research (633 citations), Hepatology (303 citations) and Oncology (563 citations). Dongxu Wang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Haitao Zhao, Junyu Long, Jianzhen Lin, Yi Bai, Xiaobo Yang, Xu Yang, Xinting Sang, Anqiang Wang, Yan Jiang and Yilei Mao. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and The Journal of Physical Chemistry B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.